Skip to main content
SpringerLink
Log in

Autoimmune Hepatitis

  • Chapter
Clinical Hepatology

  • 1875 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abe M, Onji M, Kawai-Ninomiya K, et al (2007) Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis. Clin Gastroenterol Hepatol 5: 255–8

    Article  CAS  PubMed  Google Scholar 

  2. Al-Chalabi T, Boccato S, Portmann BC, et al (2006) Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 45: 575–83

    Article  PubMed  Google Scholar 

  3. Al-Chalabi T, Underhill JA, Portmann BC, et al (2008) Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol 48: 140–7

    Article  CAS  PubMed  Google Scholar 

  4. Al-Khalidi JA, Czaja AJ (2001) Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis. Mayo Clin Proc 76: 1237–52

    Article  CAS  PubMed  Google Scholar 

  5. Alvarez F, Berg PA, Bianchi FB, et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929–38

    Article  CAS  PubMed  Google Scholar 

  6. Baeres M, Herkel J, Czaja AJ, et al (2002) Establishment of standardized SLA/LP immunoassay: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut 51: 259–64

    Article  CAS  PubMed  Google Scholar 

  7. Bayer EM, Schramm C, Kanzler S, et al (2004) Autoimmune Lebererkrankungen: Diagnose und Therapie. Z Gastroenterol 42: 19–30

    Article  CAS  PubMed  Google Scholar 

  8. Ben-Ari Z, Czaja AJ (2001) Autoimmune hepatitis and its variant syndromes. Gut 49: 589–94

    Article  CAS  PubMed  Google Scholar 

  9. Beuers U, Wiedmann KH, Kleber G, et al (1997) Therapie der autoimmunen Hepatitis, primär biliären Zirrhose und primär sklerosierenden Cholangitis. Konsensus der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten. Z Gastroenterol 35: 1041–49

    CAS  Google Scholar 

  10. Bogdanos DP, Choudhuri K, Vergani D (2001) Molecular mimicry and autoimmune liver disease: vituous intentions, malign consequences. Liver 21: 225–32

    Article  CAS  PubMed  Google Scholar 

  11. Bridoux-Henno L, Maggiore G, Johanet C, et al (2004) Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody. Clin Gastroenterol Hepatol 2: 825–30

    Article  PubMed  Google Scholar 

  12. Buchel E, van Steenbergen W, Nevens F, et al (2002) Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol 97: 3160–5

    Article  PubMed  Google Scholar 

  13. Clemente MG, Meloni A, Obermayer-Straub P, et al (1998) Two cytochromes P450 are major hepatocellular autoanti-gens in autoimmune polyglandular syndrome type 1. Gastroenterology 114: 324–8

    Article  CAS  PubMed  Google Scholar 

  14. Czaja AJ (2001) Understanding the pathogenesis of autoimmune hepatitis. Am J Gastroenterol 96: 1224–31

    Article  CAS  PubMed  Google Scholar 

  15. Czaja AJ (2008) Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis. Clin Gastroenterol Hepatol 6: 379–88

    Article  CAS  PubMed  Google Scholar 

  16. Czaja AJ, Carpenter HA (2004) Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 40: 646–52

    Article  CAS  PubMed  Google Scholar 

  17. Czaja AJ, Carpenter HA (2004) Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology 39: 1631–8

    Article  PubMed  Google Scholar 

  18. Czaja AJ, Cassani F, Cataleta M, et al (1996) Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 24: 1068–73

    Article  CAS  PubMed  Google Scholar 

  19. Czaja AJ, Doherty DG, Donaldson PT (2002) Genetic bases of autoimmune hepatitis. Dig Dis Sci 47: 2139–50

    Article  CAS  PubMed  Google Scholar 

  20. Czaja AJ, Freese DK (2002) AASLD practice guidelines: diagnosis and treatent of autoimmune hepatitis. Hepatology 36: 479–97

    Article  PubMed  Google Scholar 

  21. Czaja AJ, Kruger M, Sanrach PJ, et al (1997) Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am J Gastroenterol 92: 2197–200

    CAS  PubMed  Google Scholar 

  22. Czaja AJ, Manns MP (1995) The validity and importance of subtypes of autoimmune hepatitis: a point of view. Am J Gastroenterol 90: 1206–11

    CAS  PubMed  Google Scholar 

  23. Czaja AJ, Muratori P, Muratori L, et al (2004) Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int 24: 322–9

    Article  PubMed  Google Scholar 

  24. Czaja AJ, Rakela J, Ludwig J (1985) Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 95: 448–53

    Google Scholar 

  25. Dienes HP, Popper H, Manns M, et al (1989) Histologic features in autoimmune hepatitis. Z Gastroenterol 27: 325–30

    CAS  PubMed  Google Scholar 

  26. Dienes HP (2000) Autoimmune hepatitis. In: Denk H, Dienes HP, Düllmann J, et al (eds) Pathologie der Leber und Gallenwege, Springer Verlag, pp 379–89

    Google Scholar 

  27. Doherty DG, Donaldson PT, Underhill JA, et al (1994) Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 19: 609–15

    Article  CAS  PubMed  Google Scholar 

  28. Donaldson P, Doherty D, Underhill J, et al (1994) The molecular genetics of autoimmune liver disease. Hepatology 20: 225–9

    Article  CAS  PubMed  Google Scholar 

  29. D'Souza R, Sinnott P, Glynn MJ, et al (2005) An unusual form of autoimmune hepatitis in young Somalian men. Liver Int 25: 325–30

    Article  PubMed  Google Scholar 

  30. Duclos-Vallée JC, Sebagh M, Rifai K, et al (2003) A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence. Gut 52: 893–7

    Article  PubMed  Google Scholar 

  31. Feld JJ, Dinh H, Arenovich T, et al (2005) Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 42: 53–62

    Article  PubMed  Google Scholar 

  32. Gerotto M, Pontisso P, Giostra F, et al (1994) Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies. J Hepatol 21: 273–6

    Article  CAS  PubMed  Google Scholar 

  33. Gish RG, Mason A (2001) Autoimmune liver disease: current standards, future directions. Clin Liver Dis 5: 287–314

    Article  CAS  PubMed  Google Scholar 

  34. Heneghan MA, McFarlane IG (2002) Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 35: 7–13

    Article  CAS  PubMed  Google Scholar 

  35. Hepatology 48: 169–76

    Article  PubMed  Google Scholar 

  36. Herkel J, Heidrich B, Nieraad N, et al (2002) Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas. Hepatology 35: 403–8

    Article  CAS  PubMed  Google Scholar 

  37. Hiraide A, Imazeki F, Yokosuka O, et al (2005) Fas polymorphisms influence susceptibility to autoimmune hepatitis. Am J Gastroenterol 100: 1322–9

    Article  CAS  PubMed  Google Scholar 

  38. Inductivo-Yu I, Adams A, Gish RG, et al (2007) Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy. Clin Gastroenterol Hepatol 5: 799–802

    Article  CAS  PubMed  Google Scholar 

  39. Invernizzi P, Lleo A, Podda M (2007) Interpreting serologi-cal tests in diagnosing autoimmune liver disease. Semin Liver Dis 27: 161–72

    Article  CAS  PubMed  Google Scholar 

  40. Ishibashi H, Komori A, Shimoda S, et al 2007) Guidelines for therapy of autoimmune liver disease. Semin Liv Dis 27: 214–26

    Article  CAS  Google Scholar 

  41. Johnson PJ, McFarlane IG (1993) Meeting report of the International Autoimmune Hepatitis Group. Hepatology 18: 998–1005

    Article  CAS  PubMed  Google Scholar 

  42. Johnson PJ, McFarlane IG, Williams R (1995) Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 333: 958–63

    Article  CAS  PubMed  Google Scholar 

  43. Kanzler S, Weidemann C, Gerken G, et al (1999) Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol 31: 635–40

    Article  CAS  PubMed  Google Scholar 

  44. Kernebeck T, Lohse AW, Grötzinger J (2001) A bioinfor-matical approach suggests the function of the autoimmune hepatitis target antigen soluble liver antigen/liver pancreas. Hepatology 34: 230–3

    Article  CAS  PubMed  Google Scholar 

  45. Kessler WR, Cummings OW, Eckert G, et al (2004) Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2: 625–31

    Article  PubMed  Google Scholar 

  46. Krawitt EL (2006) Autoimmune hepatitis. N Engl J Med 354: 54–66

    Article  CAS  PubMed  Google Scholar 

  47. Langley PG, Underhill J, Tredger JM, et al (2002) Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis. J Hepatol 37: 441–7

    Article  CAS  PubMed  Google Scholar 

  48. Leuschner U (2001) Autoimmunkrankheiten der Leber und Overlapsyndrome. Uni-Med Verlag AG, Bremen

    Google Scholar 

  49. Lohr H, Manns MP, Kyriatsoulis A, et al (1991) Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis. Clin Exp Immunol 84: 297–302

    Article  CAS  PubMed  Google Scholar 

  50. Longhi MS, Ma Y, Bogdanos DP, et al (2004) Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease. J Hepatol 41: 31–7

    Article  CAS  PubMed  Google Scholar 

  51. Mackay IR, Weiden S, Hasker J (1965) Autoimmune hepatitis. Ann N Y Acad Sci 124: 767–80

    Article  CAS  PubMed  Google Scholar 

  52. Manns MP, Griffin KJ, Sullivan KF, et al (1991) LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 88: 1370–8

    Article  CAS  PubMed  Google Scholar 

  53. Manns MP, Strassburg CP (2001) Autoimmune hepatitis: clinical challenges. Gastroenterology 120: 1502–17

    Article  CAS  PubMed  Google Scholar 

  54. Manns MP, Strassburg CP (2002) Autoimmunhepatitis. Z Gastroenterol 40: 39–42

    Article  PubMed  Google Scholar 

  55. Manns MP, Vogel A (2006) Autoimmune hepatitis, from mechanisms to therapy. Hepatology 43(2 Suppl 1): S132–44

    Article  CAS  PubMed  Google Scholar 

  56. McFarlane IG (1999) Pathogenesis of autoimmune hepatitis. Biomed Pharmacother 53: 255–63

    Article  CAS  PubMed  Google Scholar 

  57. Michitaka K, Durazzo M, Tillmann HL, et al (1994) Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastroenterology 106: 1603–10

    CAS  PubMed  Google Scholar 

  58. Montano-Loza AJ, Carpenter HA, Czaja AJ (2006) Clinical significance of HLA DRB103-DRB104 in type 1 autoimmune hepatitis. Liver Int 26: 1201–8

    Article  CAS  PubMed  Google Scholar 

  59. Montano-Loza AJ, Carpenter HA, Czaja AJ (2007) Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology 46: 1138–45

    Article  CAS  PubMed  Google Scholar 

  60. Muratori L, Parola M, Ripalti A, et al (2000) Liver/kidney microsomal antibody type 1 tarhets CYP2D6 on hepatocyte plasma membrane. Gut 46: 553–61

    Article  CAS  PubMed  Google Scholar 

  61. Neuberger J, Portmann B, Calne R, et al (1984) Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting. Transplantation 37: 363–5

    Article  CAS  PubMed  Google Scholar 

  62. Pratt DS, Flavin DP, Kaplan MM (1996) The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine. Gastroenterology 110: 271–4

    Article  CAS  PubMed  Google Scholar 

  63. Pratt DS, Fawaz KA, Rabson A, et al (1997) A novel histo-logical lesion in glucocorticoid-responsive chronic hepatitis. Gastroeneterology 113: 664–8

    Article  CAS  Google Scholar 

  64. Roberts SK, Therneau TM, Czaja AJ (1996) Prognosis of histological cirrhosis in type I autoimmune hepatitis. Gastroenterology 110: 848–57

    Article  CAS  PubMed  Google Scholar 

  65. Samuel D, Riordan S, Strasser S, et al (2004) Severe autoimmune hepatitis first presenting in the early post partum period. Clin Gastroenterol Hepatol 2: 622–4

    Article  PubMed  Google Scholar 

  66. Sanchez-Urdazpal L, Czaja AJ, van Hoek B, et al (1992) Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology 15: 215–21

    Article  CAS  PubMed  Google Scholar 

  67. Schalm SW, Summerskill WHJ, Go VLW (1977) Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone. Gastroenterology 72: 910–3

    CAS  PubMed  Google Scholar 

  68. Schramm C, Herkel J, Beuers U, et al (2006) Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 101: 556–60

    Article  CAS  PubMed  Google Scholar 

  69. Singh R, Nair S, Farr G, et al (2002) Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature. Am J Gastroenterology 97: 2670–3

    Article  Google Scholar 

  70. Summerskill WHJ (1974) Chronic active liver disease reex-amined: prognosis hopeful. Gastroenterology 66: 450–64

    CAS  PubMed  Google Scholar 

  71. Summerskill WHJ, Korman MG, Ammon HV, et al (1975) Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 16: 876–83

    Article  CAS  PubMed  Google Scholar 

  72. Tahiri F, Le Naour F, Huguet S, et al (2008) Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool. Hepatology 47: 937–48

    Article  CAS  PubMed  Google Scholar 

  73. Te HS, Koukoulis G, Granger DR (1997) Autoimmune hepatitis: a histological variant associated with prominent cen-trilobular necrosis. Gut 41: 269–71

    Article  CAS  PubMed  Google Scholar 

  74. Verma S, Gunuwan B, Mendler M, et al (2004) Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transam-inases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol 99: 1510–6

    Article  PubMed  Google Scholar 

  75. Verma S, Torbenson M, Thuluvath PJ (2007) The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology 46: 1828–35

    Article  PubMed  Google Scholar 

  76. Vogel A, Liermann H, Harms A, et al (2001) Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1. Hepatology 33: 1047–52

    Article  CAS  PubMed  Google Scholar 

  77. Volkmann M, Martin L, Bäurle A, et al (2001) Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis. Hepatology 33: 591–6

    Article  CAS  PubMed  Google Scholar 

  78. Waldenström J (1950) Leber, Blutproteine und Nahrung-seiweisse. Dtsch Ges Verd Stoffw 15:113–9

    Google Scholar 

  79. Wesierska-Gadek J, Grimm R, Hitchman E, et al (1998) Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis. Gastroenterology 114: 329–35

    Article  CAS  PubMed  Google Scholar 

  80. Wiegand J, Schuler A, Kanzler S, et al (2005) Budesonide in previously untreated autoimmune hepatitis. Liver Int 25: 927–34

    Article  CAS  PubMed  Google Scholar 

  81. Wies I, Brunner S, Henninger J, et al (2000) Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 355: 1510–5

    Article  CAS  PubMed  Google Scholar 

  82. Yamamoto AM, Cresteil D, Homberg JC, et al (1993) Characterization of the anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and - negative sera. Gastroenterology 104: 1762–7

    CAS  PubMed  Google Scholar 

  83. Yokosawa S, Yoshizawa K, Ota M, et al (2007) A genom-ewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1. Hepatology 45: 384–90

    Article  CAS  PubMed  Google Scholar 

  84. Zauli D, Ghetti S, Grassi A, et al (1997) Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology 25: 1105–7

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chair, Department of Medicine II, Klinikum Offenbach, Goethe University Frankfurt/Main, Starkenburgring 66, Offenbach, 63069, Germany

    Henryk Dancygier (Professor of Medicine)

  2. Department of Medicine, Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA

    Henryk Dancygier (Professor of Medicine)

Authors
  1. Henryk Dancygier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dancygier, H. (2010). Autoimmune Hepatitis. In: Clinical Hepatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04519-6_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04519-6_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04509-7

  • Online ISBN: 978-3-642-04519-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation